Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 4
R&D Momentum
56/100
Pipeline Velocity
22/100
Trial Completion Rate
92/100
Pipeline Concentration
25/100
Pipeline Freshness
43/100
Strategic Signals
Activity
Last 14 days
Feasibility and Effectiveness of Web-based Neuropsychological Rehabilitation After Acquired Brain Injury
Protocol Based Selective Imaging Versus Routine Computed Tomography or Ultrasound in Suspected Appendicitis (PROSECCO)
Daratumumab in Monoclonal Gammopathy of Renal Significance in Finland
ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)